Continuous Compliance for Connected Medical Devices: Reducing the Time From Change to Response
How to update cybersecurity assessments and controls between scheduled reviews.
How to update cybersecurity assessments and controls between scheduled reviews.
New guidance identifies low-risk devices in eight medical specialties that will no longer require 510(k) submissions to reduce regulatory burdens.
The partnership between the Food and Drug Administration and the Medicines and Healthcare products Regulatory Agency aims to streamline technology access and reduce regulatory duplication.
How to update cybersecurity assessments and controls between scheduled reviews.
Revised guidance aligns with quality management system regulation changes and provides recommendations for cyber device submissions under section 524B of the FD&C Act.
Read MoreThe agency exceeded its three-month termination timeline for 74% of recalls during fiscal years 2020-2024, due to staff constraints that limited oversight activities, the report finds.
Read MoreThe hospital association urges the FDA to adopt risk-based post-market oversight for AI-enabled medical devices while aligning new requirements with existing regulatory frameworks.
Read MoreNew guidance permits the use of de-identified data without requiring individual patient information in marketing submissions.
Read MoreThe pilot will evaluate a new, risk-based enforcement approach that supports digital health devices intended for use in chronic conditions.
Read MoreThe software is intended to help manufacturers demonstrate cybersecurity maturity as expectations from regulators and hospital purchasers continue to rise.
Read MoreThe agency is requesting public comment on methods for monitoring and evaluating AI models after deployment to ensure continued safety and effectiveness.